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Treatment of pregnant ferrets with 15 mg/kg of methylazoxymethanol acetate (MAM)at 33 days of fetal gestation results in off- 
spring with cortical hypoplasia and lissencephally. Neurochemical analysis of 5 areas of cortex from 8-week-old offspring of MAM- 
or vehicle-treated jills indicated an overall enrichment in markers for catecholaminergic (tyrosine hydroxylase, norepinephrine) and 
cholinergic (choline acetyltransferase, acetylcholine) terminals but minimal change in the concentration of GABAergic markers 
(glutamate decarboxylase, 7-aminobutyric acid); however, there did not appear to be a direct, inverse relationship between the 
concentration of catecholaminergic and cholinergic markers and the degree of hypoplasia in cortical subareas unlike what has been 
found previously in the rat. 
INTRODUCTION 
Methylazoxymethanol acetate (MAM) is a potent 
alkylating agent that kills mitotically active cells by 
selectively methylating nucleic acids 21. MAM has 
been shown to have neurotoxic effects when admini- 
stered during the period of active neurogenesis in 
hamsters, mice, rabbits, rats, beagles, cats and fer- 
rets 17. Since the compound has a brief half-life in 
vivo, timing of fetal or perinatal exposure in relation 
to regional neurogenesis determines the character of  
CNS malformations 17,21. In rats, injection of  MAM 
on fetal day 15 eliminates many neurons destined for 
the outer half of  the neocortex but spares important 
brainstem projections to the neocortex that are 
formed prior to the date of  administrationlO, n.  
Analysis of  D N A  in the brain of  adult rats treated 
on day 15 indicate a marked loss of  cells in the cere- 
bral hemispheres but not in the brainstemlL In addi- 
tion, neurochemical and immunocytochemical stu- 
dies of  transmitter-specific neuronal populations 
reveal a marked loss of  GABAergic neurons intrin- 
sic to the hypoplastic cortex but a relative enrich- 
ment of  noradrenergic, serotonergic and cholinergic 
terminals derived from the brainstem 10-12. Varying 
the fetal age of  treatment with MAM in the rat pro- 
duces a predictable spectrum of changes in the 
neurochemical and histologic composition of the 
cortex 14. 
Morphologically, MAM lesions in fetal rats re- 
semble human malformations characterized by lis- 
sencephaly, a flattening of  the normal gyral pattern 
of  the cortexg, 16. Gyrencephalic animals such as the 
ferret provide a better model for these malforma- 
tions since rat cortex lacks gyri. Previous studies 
indicate that ferrets exposed to MAM in the last 
quarter of  gestation develop lissencephalic cortices 
and also exhibit deficits in learning as measured by 
maze performance 8. The present study was under- 
taken to determine whether MAM-induced cortical 
hypoplasia in the ferret is associated with alterations 
in neurotransmitter-specific neuronal populations 
that have been previously described in the rat. 
Accordingly, we have assayed neurochemical mar- 
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kers for GABAergic, cholinergic and catecholamin- 
ergic neurons in the neocortex from juvenile ferrets 
which received MAM on gestational day 33. 
MATERIALS AND METHODS 
Animals 
Time-dated pregnant ferret jills were purchased 
from Marshall Research Animals (Northrose, New 
York) and were fed and housed as previously de- 
scribed 6. Each jill was given a single intraperitoneal 
injection of either methylazoxymethanol acetate (15 
mg/kg body weight; Aldrich Chemicals, St. Louis, 
MO) or an equivalent volume of physiologic saline 
on day 33 of  gestation. Pups were born 9 days later, 
weaned at 6 weeks of age and sacrificed at 8 weeks of 
age by decapitation for histologic and neurochemi- 
cal analysis. Five control and 4 lesioned ferrets from 
2 litters each were used in the experiments. 
Morphology 
To correlate the anatomical and neurochemical 
data, brains of animals sacrificed by cervical disloca- 
tion were removed from the skull, weighed and divi- 
ded in half longitudinally. One half was placed in cold 
10 % buffered formalin for 3 weeks and then immer- 
sed in 30 ~ sucrose in buffered formalin for 10 days. 
After photographs were obtained to record the gross 
appearance of  the brain, 40 /~m coronal sections 
were obtained on a frozen stage microtome plane 
and stained with cresyl violet. 
Neurochemical analysis 
One-half of  the brain was quickly dissected on an 
ice-cold aluminum block. The hemicortex was isola- 
ted by dissecting away all tissue below the cortical 
white matter. The cortices were then flattened on the 
aluminum plate with the white matter down and the 
dorsomedial cingulate and entorhinal cortex were 
cut away. The remaining cortex was divided into 5 
regions as shown in Fig. 1 for neurochemical analy- 
sis. Although the gyral landmarks were obscured in 
the MAM treated cortex, an attempt was made to 
dissect regions analogous to those of control cortex. 
The cortical samples were then cut into blocks, 
which were frozen immediately on dry-ice and 
stored at - -70 °C for assay of  neurotransmitter syn- 
thesizing enzymes or endogenous neurotransmitters. 
For neurochemical assays, samples from both age- 
matched control and MAM-lesioned animals were 
assayed at the same time. 
For enzyme assays, the tissue was homogenized in 
20 vols. of ice-cold 50 mM Tris-HCl, pH 7.4 con- 
taining 0.2 % (v/v) Triton X-100. Homogenates were 
centrifuged at 12,000 g at 4 °C for 15 min and por- 
tions of the supernatant were assayed. Activity of 
choline acetyltransferase was measured by the meth- 
od of Bull and Oderfeld-Nowak 1, tyrosine hydroxy- 
lase was measured as described by Coyle and Axel- 
rod 2 with the exception that o,L-methyl-5,6,7,8-te- 
trahydropterine-HC1 was used as the co-factor. Glu- 
tamate decarboxylase was assayed by a modification 
of the method of Wilson et al. 24 with D,L-[1-14C]glu- 
tamic acid as substrate with the exception that pH 
was lowered to an optimum of 5.5. Protein was mea- 
sured by the method of Lowry et al. is with bovine 
serum albumin as standard. To assay the neuro- 
transmitters, the frozen cortex was homogenized in 
20 vols. of formic acid-acetone (15:85, v/v). Homo- 
genates were centrifuged at 1000 g for 5 min, and the 
supernatant was aliquoted into tubes for each assay 
and dried down in a vacuum centrifuge. Norepine- 
phrine was measured by the method of Coyle and 
Henry 3, GABA by the method of Graham and Apri- 
son~, and acetylcholine by the method of Goldberg 
and McCaman 4. All neurochemical assays were 
done in triplicate. 
RESULTS 
Morphology 
MAM-treatment of ferrets at 33 days gestation 
resulted in offspring with brain weight reduced by 
28 ~o as compared to age-matched controls (MAM, 
5.0 ± 0.2 g vs control, 6.9 :k 0.2 g; P < 0.01). Al- 
though the brainstem and cerebellum appeared rela- 
tively normal in the affected offspring, MAM treat- 
ment markedly impaired the normal development of 
the gyral pattern of the cerebral cortex (Fig. 1). The 
frontal cortical mantle, normally formed by the 
suprasylvian, middle and sigmoid gyri, was consi- 
derably reduced although the most rostral frontal 
pole was less severely affected. The perisylvian gyral 
pattern was obliterated and the cortex in the tempo- 
ral-occipital region was severely hypoplastic and 
remained as a thin, transparent membrane suppor- 
Fig. 1. Gross morphology of the ferret brain. A: the brain of a 
normal ferret. B : the brain from a ferret treated with MAM at 
33 days of gestation. The cortical sub-areas used for neuro- 
chemical assays are indicated. Note marked attenuation and 
ablation of the cortical gyrae in the MAM-treated rat cortex 
and the sunken temporal cortex resulting from the severe 
atrophy (asterisk). Abbreviations: F, frontal pole; P, prefron- 
tal; L, lateral gyrus; S, suprasylvian gyrus; E, ectosylvian 
gyrus. 
ted in life by the cerebral spinal fluid within the 
dilated ventricles. Only the presylvian and suprasyl- 
vian fissures were readily apparent in most treated 
animals. Histologic examination of the midlateral 
cortex of the MAM-treated ferret revealed marked 
hypoplasia affecting primarily the outermost layers 
(Fig. 2). Although the molecular layer appeared 
relatively normal, many solitary neurons and neuro- 
nal clumps were ectopically placed in the deep 
cortex and subcortical regions. 
Neurochemistry 
Although there was considerable variation among 
the subregions of the cortex, the lissencephalic cor- 
tex of the MAM-treated ferrets was generally en- 
riched in biochemical markers for cholinergic and 
catecholaminergic neurons but deficient in markers 
for the GABAergic neurons (Tables I and II). Not- 
ably, no difference in protein content per mg brain 
tissue was observed in any regions examined between 
the treated and control ferrets. In the 5 regions ex- 
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amined, the mean increase in the specific activity of  
tyrosine hydroxylase, an enzymatic marker for cate- 
cholaminergic axons, was 39 70; similarly, the concen- 
tration of endogenous norepinephrine was elevated 
on an average of 38 ~ overall. In contrast, the con- 
centration of  endogenous GABA was reduced by an 
average of 17 700 and the specific activity of its syn- 
thetic enzyme, glutamate decarboxylase, was re- 
duced by 14700. The specific activity of choline 
acetyltransferase was increased by 4970 overall 
whereas endogenous acetylcholine was generally ele- 
vated but to a lesser extent. 
The presynaptic markers for the catecholaminer- 
gic axons in neocortex, tyrosine hydroxylase and 
endogenous norepinephrine, were both significantly 
elevated in the prefrontal, ectosylvian and suprasyl- 
vian regions, but were less affected in the frontal 
pole and the lateral gyrus regions. Although the ele- 
vations in both markers were comparable in the 
ectosylvian and suprasylvian regions, it is note- 
worthy that tyrosine hydroxylase activity was in- 
creased to a disproportionately greater extent in the 
prefrontal region as compared to the concentration 
of norepinephrine; this disparity may reflect the 
greater localization of tyrosine hydroxylase in dop- 
aminergic axons within this region. 
The reductions in the concentration of endoge- 
nous GABA were relatively modest and evenly 
distributed throughout all regions. These altera- 
tions, which reach statistical significance only in the 
lateral regions, were consistent with the small reduc- 
tions in the specific activity of glutamate decarboxy- 
lase, except in the frontal pole where a 59 ~ decrease 
in enzyme activity was noted. Regional alterations 
in cholinergic markers differed from the pattern ob- 
served with the catecholaminergic markers. While 
the prefrontal section contained the greatest eleva- 
tions in the specific activity of choline acetyltrans- 
ferase, the frontal pole was the site of the next 
highest increase in choline acetyltransferase activity. 
The increase in choline acetyltransferase activity in 
the suprasylvian region was virtually identical to 
those observed with tyrosine hydroxylase and endo- 
genous norepinephrine. Increases in the concentra- 
tion of  endogenous acetylcholine generally occurred 
in regions in which the activity of its synthetic 
enzyme was elevated although the alterations in the 
neurotransmitter were much less marked. 
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Fig. 2. Histology of the mid-lateral cortex of the ferret. A: normal ferret. B: ferret treated with MAM at 33 days of gestation. 
Photomontages were obtained from Nissl-stained sections through the mid-lateral cortices from adult control and MAM-lesioned 




Neurotransmitter synthesizing enzyme activity in ferret cortex aJ?er prenatal treatment with MAM acetate 
Enzyme specific activities were determined in cortical regions of the lissencephalic MAM acetate-treated brains and compared 
with analogous regions shown in Fig. 1. Each value (mean 4- S.E.M.) is the result of duplicate determinations performed in 5 control 
and 4 treated animals. 
Area Tyrosine hydroxylase Choline acetyltransferase Glutamate decarboxylase 
(pmol.h-l.mg prot.-t) (nmol.h-l.mg prot. -1) (nmol.h-l.mg prot.-1) 
Control Treated A % Con t ro l  Treated A % C o n t r o l  Treated d % 
Frontal pole 28 4- 2 31 4- 1 +11 16.6 4- 2 28.1 4- 2* --61 7.1 4- 0.8 2.9 ± 0.8** --59 
Prefrontal 53 :[: 4 91 4- 7** +72 19.4 :t: 2 42.3 4- 6** +118 5.9 4- 0.3 5.9 -4- 0.3 0 
Lateral gyrus 26 ± 3 31.6 4- 2 +16 16.5 4- 2 16.5 4- 3 0 6.5 4- 0.4 6.2 4- 0.8 - -5  
Suprasylvian gyrus 36 4- 2 50 4- 5* +39 17.3 + 1 24.1 + 1"* +39 5.9 ± 0.4 5.7 4- 0.3 - -3  
Ectosylvian gyrus 27 4- 2 42 4- 3** +59 33.5 4- 3 43.0 + 6 +28 7.5 4- 0.3 7.2 4- 0.7 - -4  
* P < 0.05; ** P < 0.01 ; control vs treated (Student's t-test). 
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TABLE 11 
Endogenous neurotransmitter levels in ferret cortex after prenatal treatment with M A M  acetate 
Endogenous neurotransmitter concentrations were determined in regions of untreated cortex (Fig. 1) and analogous regions of 
lissencephalic MAM acetate-treated cortex. Each value (mean ± S.E.M.) is the result of duplicate determinations performed in 
5 control and 4 treated animals. ND, not determined. 
Area Norepinephrine (pg/mg tissue) GABA (nmol/mg tissue) 
Control Treated A ° o Control Treated 
Aeetyleholine (pmol/mg tissue) 
A % Control Treated A ° o 
Frontal pole 150 ± 25 170 ± 26 % 11 1.29 i 0.04 1.19 ± 0.02 --8 12.6 -4- 0.6 13.8 ± 0.08 +10 
Prefrontal 150 :~ 20 210 ± 4* +40 1.26 z~ 0.03 1.04 ± 0.09 --17 10.4 ± 0.4 14.9 ± 1.5" +43 
Lateral gyrus 190 ± 17 220 ~ 30 t- 16 1.24 ± 0.05 1.01 -4- 0.07 --19 12.0 ± 0.6 13.6 ± 0.05 -q 13 
Suprasylvian gyrus 152 ± 22 219 ± 9* +44 1.25 ~ 0.06 1.00 ± 0.06* --20 10.8 zL 0.03 9.5 -? 1.4 --12 
Ectosylvian gyrus 140 ± 13 250 ± 23"* +80 1.32 i 0.04 1.06 ± 0.01 ** --21 ND 
* P < 0.05; ** P < 0.01 ; control vs treated (Student's t-test). 
DISCUSSION 
The results of the present experiments with fetal 
MAM lesions of ferret are generally congruent with 
our previous findings in the rat which have shown 
significant imbalances among cortical neurotrans- 
mitter systems i°-1z,14AS,2°,23. Although the most 
characteristic neuroanatomic feature of  the lesioned 
cortex is hypoplasia, the neurochemical analyses 
reveal supernormal concentrations of markers for 
cortical catecholaminergic and cholinergic terminals. 
The presynaptic markers for GABAergic neurons 
were generally unchanged or mildly reduced in con- 
centration but markedly depressed when considered 
in terms of their total amounts per cortex. 
Previous studies in the rat indicate that the short- 
acting alkylating agent MAM selectively ablates 
neurons in the CNS which are dividing at the time of 
administrationV,X4,19,2L Because the neurons ma- 
king up the neocortex divide relatively late in gesta- 
tion s, rather selective deletions of neocortical lami- 
nae can be produced by administration of MAM 
when most brainstem systems have ceased dividing 
and have begun differentiation. Similarly, admini- 
stration of MAM at the beginning of the last week 
of gestation for the ferret results in a marked cortical 
hypoplasia whereas the brainstem and cerebellum 
are relatively spared< An important distinction be- 
tween the gyrencephalic ferret and the lissencephalic 
rat concerns the disruption of normal gyral forma- 
tion in the ferret after the late fetal MAM lesion. 
Thus, the effects of the lesion in ferret is not simply 
restricted to cortical thickness but macroscopic as- 
pects of neocortical organization. 
The neocortical GABAergic neurons, aspinous 
stellate cells, are evenly distributed throughout all 
cortical layers2L Congruent with this distribution, 
neurochemical analysis in the cortex of the fetal 
MAM-lesioned rat indicated no alteration in the 
concentration of presynaptic markers for the 
GABAergic neurons but a reduction directly pro- 
portional to the degree of cortical hypoplasia. In 
contrast, the presynaptic markers for the noradren- 
ergic terminals innervating the cortex were increased 
in concentration in the MAM-lesioned rat cortex in 
inverse proportion to the degree of hypoplasia; this 
reflected the quantitatively normal development of 
the noradrenergic terminal arbor which was com- 
pressed in the reduced cortical volume 1°,11. A simi- 
lar enrichment in the presynaptic markers of the 
cholinergic terminals was noted in the MAM-in- 
duced hypoplasia of the rat neocortex although the 
total concentration of the cholinergic markers were 
significantly reduced consistent with the evidence for 
a population of cortical cholinergic intrinsic neurons 
that would be affected by the MAM lesion. 
Although the regional morphologic-neurochemi- 
cal analysis in the MAM-lesioned ferret cortex was 
generally consistent with the findings in the rat, 
certain dissimilarities are also apparent. It was not 
possible in the ferret to determine the total amount 
of markers per cortical mantle; nevertheless, a sim- 
ple inverse relationship between the concentration 
of noradrenergic terminal markers and the degree of 
hypop las i a  o f  subregions  o f  the  cor tex  d id  no t  
appea r  to  hold .  Whi le  regions o f  the  ferret  cor tex  
which were marked ly  affected morpho log ica l ly  (pre- 
f rontal ,  supersylvian and  ectosylvian regions)  exhi- 
b i ted  the largest  increase in ca techolaminerg ic  mar-  
kers,  o ther  clearly affected regions such as the  la tera l  
gyrus exhibi ted  only modes t  e levat ions tha t  were not  
consis tent  with the degree o f  hypoplas ia .  Similarly,  
the  e levat ions in the presynapt ic  chol inergic  mar-  
kers,  while greatest  in the severely affected area,  the 
pref ronta l  region,  also exhibi ted a subs tant ia l  in- 
crease in the f ronta l  pole,  which was less severely 
affected. Curiously,  the f ronta l  pole  also exhibi ted a 
significant reduc t ion  in the specific act ivi ty o f  gluta-  
mate  decarboxylase ,  a l though the concent ra t ion  o f  
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